Advances in the treatment of virus diseases.
D000547:Amantadine / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D001665:Binding Sites; D005759:Gastroenteritis / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007251:Influenza, Human / Q000188:drug therapy; D007372:Interferons / Q000627:therapeutic use; D011213:Poxviridae Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D013882:Thiosemicarbazones; D014777:Virus Diseases / Q000188:drug therapy*; D014779:Virus Replication / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D013256:Steroids; D013882:Thiosemicarbazones; D007372:Interferons; D000547:Amantadine; D007065:Idoxuridine; D012293:Rifampin